On ECHEMI
Home > Drugs > Ribavirin Dispersible Tablets

Ribavirin Dispersible Tablets

Function and Efficacy

Pharmacology: Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

Ingredients

The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide.

Name Description Content CAS NO. Manufacturer
RibavirinIngredients

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses in vitro, including respiratory syncytial virus, influenza virus, hepatitis A virus, and adenovirus. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase, and mRNA guanosine transferase, thereby causing a reduction in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More
36791-04-5 33

Appearance

This product is white tablets.

Indication

It is suitable for viral pneumonia and bronchitis caused by respiratory syncytial virus, and herpes virus infection of the skin.

Usage and Dosage

Oral 1. Viral respiratory tract infection: Adults take 0.15g once, 3 times a day, for a course of 7 days. 2. Skin herpes virus infection: Adults take 0.3g once, 3 times a day, for a course of 7 days. 3. Children take 10mg/kg per day, divided into 4 doses, for a course of 7 days.

Adverse Reactions

Common adverse reactions include anemia and fatigue, which disappear after stopping the drug. Less common adverse reactions include fatigue, headache, insomnia, loss of appetite, nausea, vomiting, mild diarrhea, constipation, etc., and can cause a decrease in red blood cells, white blood cells and hemoglobin.

Precautions

It is forbidden for people who are allergic to this product and pregnant women.

Special Population Medication

Precautions for children: The oral dose for children under 6 years old has not been determined. Precautions for pregnancy and lactation: 1. This product has a strong teratogenic effect. A daily dose of 1mg/Kg in rabbits can cause embryo damage, so it is forbidden to use it in pregnant women and women who may become pregnant (this product is eliminated very slowly in the body and cannot be completely eliminated from the body 4 weeks after stopping the drug). 2. A small amount of the drug is excreted through breast milk and is toxic to both mother and offspring. Therefore, breastfeeding women should stop breastfeeding during the medication period and the breast milk should also be discarded. Since respiratory syncytial virus infection in lactating women is self-limiting, this product is not used in such cases. Precautions for the elderly: It is not recommended for the elderly.

Drug Interactions

This product has an antagonistic effect when used together with zidovudine, because this product can inhibit the conversion of zidovudine into active zidovudine phosphate.

Storage

Keep tightly closed in a cool, dry place.

Packaging Specification

50mg

Validity Period

24 months

Manufacturer

Chengdu DIAO Jiuhong Pharmaceutical Factory

  • Founded in:

    1996-11-27
  • Address:

    No. 16, Gaopeng East Road, Chengdu Hi-tech Zone
  • Tax NO.:

    91510100202172097P
  • Registered Funds:

    10 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.